Privia Health Group Files 8-K

Ticker: PRVA · Form: 8-K · Filed: 2025-08-29T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, disclosure, exhibits

Related Tickers: PRVA

TL;DR

PRVA filed an 8-K for a Reg FD disclosure and exhibits. Standard update.

AI Summary

Privia Health Group, Inc. filed an 8-K on August 29, 2025, reporting an event on August 28, 2025. The filing is primarily a Regulation FD Disclosure and includes Financial Statements and Exhibits. No specific financial transactions or material events are detailed in the provided text, but it indicates a standard reporting update.

Why It Matters

This filing indicates Privia Health Group, Inc. is making a regulatory disclosure and submitting financial exhibits, which is a standard but important part of public company reporting.

Risk Assessment

Risk Level: low — The filing appears to be a routine disclosure and submission of exhibits, with no immediately apparent negative or positive material events described.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Privia Health Group, Inc.?

The primary purpose is a Regulation FD Disclosure and the submission of Financial Statements and Exhibits, as indicated by the filing's item information.

On what date was the earliest event reported in this 8-K filing?

The earliest event reported was on August 28, 2025.

What is the exact name of the company filing this report?

The exact name of the registrant is Privia Health Group, Inc.

In which state was Privia Health Group, Inc. incorporated?

Privia Health Group, Inc. was incorporated in Delaware.

What is the address of Privia Health Group, Inc.'s principal executive offices?

The address of Privia Health Group, Inc.'s principal executive offices is 950 N. Glebe Rd., Suite 700, Arlington, Virginia 22203.

From the Filing

0001759655-25-000096.txt : 20250829 0001759655-25-000096.hdr.sgml : 20250829 20250828174933 ACCESSION NUMBER: 0001759655-25-000096 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250828 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250829 DATE AS OF CHANGE: 20250828 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Privia Health Group, Inc. CENTRAL INDEX KEY: 0001759655 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40365 FILM NUMBER: 251275000 BUSINESS ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-366-8850 MAIL ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 FORMER COMPANY: FORMER CONFORMED NAME: PH Group Parent Corp. DATE OF NAME CHANGE: 20181120 8-K 1 prva-20250828.htm 8-K prva-20250828 0001759655 FALSE 0001759655 2025-08-28 2025-08-28 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K _______________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2025 _________________________ Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) _________________________ Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organization) (Commission File No.) (I.R.S. Employer Identification No.) 950 N. Glebe Rd., Suite 700 Arlington, Virginia 22203 (Address of Principal Executive Offices) (Zip Code) ( 571 ) 366-8850 Registrant's telephone number, including area code Not Applicable (Former name, former address and former fiscal year, if changed since last report) Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01. Regulation FD Disclosure On August 28, 2025, Privia Health Group, Inc. (the “Company”) issued a press release announcing its 2024 performance results in the Medicare Shared Savings Program and preliminarily increasing its Adjusted EBITDA guidance for full-year 2025 to a range of $113-$116 million. A copy of the press release is attached hereto as Exhibit 99.1. The materials are attached as Exhibit 99.1 to this Current Report on Form 8-K, are incorporated into this Item 7.01 by reference and are available on our investor relations website at ir.priviahealth.com. This information may be amended or updated at any t

View on Read The Filing